Home › Funds › Empower › Empower International Growth Fund
Fund family: Empower · Filed by EMPOWER FUNDS, INC. (CIK 356476) · SEC series S000023737
Share classes and tickers: MXHTX (C000155764), MXIGX (C000069814)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,133 with, 2 against, 1 abstentions (not counted as with management); 58 items carried no recommendation; 1 split votes are in neither count. Shareholder proposals: 4 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Empower’s manager page (82,158 ballot items across 37 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Empower | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 96.7% | 913 | 94.5% | 64,282 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 7.9% | 519 |
Each ballot item this fund voted is set against the votes of the other Empower funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Empower funds on 8 items (2.7% of the 299 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Empower funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| EssilorLuxottica SA | 2026-04-28 | Reelect Andrea Zappia as Director | For | AGAINST — 3 of 3 Empower funds | For | — |
| Novonesis (Novozymes A/S) | 2026-03-23 | Reelect Kasim Kutay Lane as Director | For | ABSTAIN — 3 of 3 Empower funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Approve Variable Remuneration of Executive Committee in the Amount of CHF 30.6 Million | For | AGAINST — 2 of 3 Empower funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Reelect Anton Rupert as Director | For | AGAINST — 2 of 3 Empower funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Reelect Gary Saage as Director | For | AGAINST — 2 of 3 Empower funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Reelect Johann Rupert as Director and Board Chair | For | AGAINST — 2 of 3 Empower funds | For | — |
| EssilorLuxottica SA | 2026-04-28 | Approve Compensation Report of Corporate Officers | For | AGAINST — 2 of 3 Empower funds | For | — |
| Novonesis (Novozymes A/S) | 2026-03-23 | Reelect Heine Dalsgaard (Vice Chair) as Director | Abstain | FOR — 2 of 3 Empower funds | Against | — |
Download all 8 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 485 | 0 |
| Corporate Governance | 245 | 1 |
| Capital Structure | 190 | 0 |
| Compensation | 126 | 0 |
| Audit-related | 66 | 0 |
| Say-on-Pay | 49 | 0 |
| Other | 17 | 0 |
| Other Social Issues | 9 | 0 |
| Environment or Climate | 4 | 1 |
| Extraordinary Transactions | 2 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 30, 2026 | Kao Corp. | Appoint Three Individuals to Investigate Status of Operations and Property of the Company including Potential Failures of Risk Management, Internal Controls and Board Oversight related to Palm Oil, Paper and Pulp Supply Chains Shareholder proposal | Against | For |
| March 23, 2026 | Novonesis (Novozymes A/S) | Account for Ethical Policies and Ensure Compliance Frameworks in Practice Shareholder proposal | Against | For |
1,194 ballot items at 72 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Empower International Growth Fund (MXHTX) voted at 72 shareholder meetings of 68 companies, on 1,194 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 2 times. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 7 shareholder proposals. It voted FOR the board's own proposals more often than Empower's funds as a whole (96.7% against 94.5%). It voted differently from most Empower funds on 8 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Empower’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.